top of page

Latest News

Owl Therapeutics to Present at the 2025 Biotech Showcase Conference

January 9, 2025 at 9:30:00 PM

Owl Therapeutics to present novel approach to Unlocking the Traumatic Brain Injury Market

September 9, 2024 at 5:00:00 PM

Owl Therapeutics to Present Latest Data at the RESI JPM San Francisco 2024 Conference

January 4, 2024 at 11:00:00 PM

Owl Therapeutics Enters a Strategic Clinical Collaboration With Abliva to Advance NeuroSTAT® (OWL-1410) for Traumatic Brain Injury

November 17, 2023 at 11:00:00 PM

Abliva and Owl Therapeutics enter into licensing and collaboration agreement for NeuroSTAT® in Traumatic Brain Injury

November 14, 2023 at 11:00:00 PM

bottom of page